Compare ATRC & FIHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | FIHL |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2005 | 2023 |
| Metric | ATRC | FIHL |
|---|---|---|
| Price | $41.73 | $19.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $52.00 | $21.14 |
| AVG Volume (30 Days) | 544.9K | ★ 569.8K |
| Earning Date | 10-29-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 3.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $518,304,999.00 | ★ $2,573,400,000.00 |
| Revenue This Year | $16.90 | $9.83 |
| Revenue Next Year | $12.29 | $9.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.80 | 11.89 |
| 52 Week Low | $28.29 | $14.17 |
| 52 Week High | $43.11 | $19.71 |
| Indicator | ATRC | FIHL |
|---|---|---|
| Relative Strength Index (RSI) | 69.29 | 59.26 |
| Support Level | $38.92 | $17.87 |
| Resistance Level | $41.12 | $19.33 |
| Average True Range (ATR) | 1.81 | 0.36 |
| MACD | 0.64 | -0.02 |
| Stochastic Oscillator | 92.49 | 81.16 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.